Your browser doesn't support javascript.
loading
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.
Yu, Su-Yeon; Koh, Dae-Hyup; Choi, Miyoung; Ryoo, Seungeun; Huh, Kyungmin; Yeom, Joon Sup; Yoon, Young Kyung.
Afiliación
  • Yu SY; Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.
  • Koh DH; Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.
  • Choi M; Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.
  • Ryoo S; Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea.
  • Huh K; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Yeom JS; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yoon YK; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Emerg Microbes Infect ; 11(1): 1154-1165, 2022 12.
Article en En | MEDLINE | ID: mdl-35343397

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article